Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F20MH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,272
Award facts
- Contract value 100% obligated
- $18,272.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,272.07 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials, a pharmaceutical product supporting federal medical procurement needs. This firm fixed-price contract, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, is a non-set-aside award issued competitively. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor providing critical medical supply chain support to federal agencies, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products across multiple therapeutic domains, from specialty medications and brand-name drugs to vaccines and medical devices. The firm fixed-price delivery order structure and competitive award process reflect AmerisourceBergen's established position as a qualified federal contractor meeting stringent procurement requirements for essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F20MH?
SPE2DR26F20MH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F20MH worth?
The government has obligated $18,272 on SPE2DR26F20MH.
Is contract SPE2DR26F20MH an order under another contract?
Yes. SPE2DR26F20MH is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20MH competed?
The extent of competition for SPE2DR26F20MH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award